12-Dose Regimen for Latent TB Infection - Patient Education Materials

12-Dose Regimen for Latent TB Infection - Patient Education Materials

Author: Centers for Disease Control and Prevention (CDC), National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, Division of Tuberculosis Elimination
Publication Date: 2018
Country of Origin: United States
Format: Brochure
Language: English

Abstract

The materials were developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The materials include a patient education brochure, medication tracker, and symptom checklist. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events. The medication tracker includes space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

Publisher:

CDC NCHHSTP Division of Tuberculosis Elimination

Audience(s):

Health Professionals, Persons With LTBI, Physicians

Topic:

Diagnosis, TB Treatment, Treatment - Latent TB infection (Inactive TB), Treatment- Medication Information, Treatment- Patient Adherence

Notes:

Materials available in English, Chinese, Haitian Creole, Marshallese, Spanish, Tagalog, and Vietnamese Languages.

Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.